Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Schizophrenia Research|May 6, 2003
Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New ZealandOye Gureje, Wayne Miles, Nicholas Keks, et al.Annals of Hematology|May 8, 2010
Diagnosis and management of chronic ITP: comments from an ICIS expert groupJohn David Grainger, Paula H B Bolton-Maggs, Bertrand Godeau, et al.Fertility and Sterility|November 26, 2013
WITHDRAWN: Initiation of the Society for Assisted Reproductive Technology Donor Egg Registry: a report from the Donor Egg Registry Task Force, David Grainger, Judy E Stern, et al.Plos One|August 24, 2012
Urinary bisphenol a concentration and angiography-defined coronary artery stenosisDavid Melzer, Phil Gates, Nicholas J Osborne, et al.American Journal of Obstetrics and Gynecology|October 4, 2003
Antenatal factors associated with significant birth weight discordancy in twin gestationsVctor H González-Quintero, Barbara Luke, Mary J O'sullivan, et al.The British Journal of Radiology|November 13, 2024
A framework for developing generic implant safety procedures for scanning patients with medical implants and devices in MRIJonathan P Ashmore, Sarah J Prescott, John McLean, et al.Circulation. Cardiovascular Genetics|December 25, 2009
Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaquesManuel Mayr, David Grainger, Ursula Mayr, et al.International Journal of Technology Assessment in Health Care|June 3, 2022
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task ForceWija Oortwijn, Don Husereau, Julia Abelson, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task ForceWija Oortwijn, Don Husereau, Julia Abelson, et al.Journal of Minimally Invasive Gynecology|October 1, 2016
A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up ResultsPhilippe Laberge, Jose Garza-Leal, Claude Fortin, et al.Pageof 4